Resumen

APODACA, Elia; HERNANDEZ-PEREZ, Carlos R.  y  RODRIGUEZ-GONZALEZ, María Guadalupe. Management of patients with Myelodysplastic Syndrome in the COVID-19 era. Gac. Méd. Méx [online]. 2021, vol.157, suppl.3, pp.S47-S51.  Epub 25-Abr-2022. ISSN 2696-1288.  https://doi.org/10.24875/gmm.m21000470.

SARS-CoV-2 infection has caused a change in the way we care for patients with hematological diseases around the world. Patients with myelodysplastic syndrome (MDS) have been affected by the lack of knowledge of the behavior of COVID-19 in this type of condition. International guidelines have been established that have made it possible to continue caring for these patients. The main objective of this review is to define the preventive measures and treatment strategies that should be taken when evaluating a patient with myelodysplastic syndrome in the COVID-19 era.

Palabras llave : COVID-19; Myelodysplastic syndrome (MDS); Patients.